Diabetes, Stroke, and Cognitive Impairment

Previous studies have shown that people with diabetes have worse outcomes after stroke. The Stroke and Cognition (STOKOG) Collaboration study looked closely at prediabetes (impaired fasting glucose) and type 2 diabetes to determine which condition causes worse cognitive function in patients 3 to 6 months after stroke. Read more

Will People with Prediabetes Use CGM?

Dexcom’s G6 Pro CGM seeks to increase use in people with prediabetes through its “blinded” mode. The G6 Pro, which consists of a sensor and transmitter unit, can store up to 10 days of glucose readings on the transmitter. These readings can then be read and analyzed retrospectively by a health care professional. Read more

How Food Choices Impact Risk of Death

A large study of Taiwanese people with type 2 diabetes examined the relationship between the intake of macronutrients, such as carbohydrates, proteins, and fats, and mortality. The researchers found dietary patterns affect men and women differently. Read on

Preventing Type 1 May Become a Reality

Teplizumab may become the first antibody commercially available that can halt or delay the progression of type 1 diabetes. Researchers have found that a single 14-day infusion of teplizumab leads to a median 3-year delay in type 1 diabetes onset in high-risk individuals. Read more

New Test May Predict Post-Gestational Type 2

The Centers for Disease Control (C.D.C.) estimates that 2% to 10% of pregnant women will develop gestational diabetes (G.D.M.), and of women with G.D.M, up to 50% will go on to develop type 2 diabetes (T2D). Current testing to predict which women are at greater risk for T2D is cumbersome, but a new test may […]

Tandem Acquires Sugarmate App

Tandem Diabetes has announced it has acquired Sugarmate, a popular app for people with diabetes who use insulin. The app allows patients to track of glucose levels and health/nutrition information, and notifies users and care providers about any fluctuation. For now, Sugarmate will continue to operate as a standalone entity and continue to provide services […]

Once-Weekly Insulin Shows Promise for Type 2

Currently there is no such thing available as a once-weekly insulin product. However, a new type of insulin, called insulin icodec, is showing promise in testing, and may one day offer people with type 2 a more convenient option for taking insulin. Read more

Could Trulicity Help Prevent Dementia?

Recent research into the glucagon-like peptide-1 (GLP-1) receptor agonist drug dulaglutide (Trulicity) suggest it may lower cognitive decline in type 2 diabetes, possibly in association with reduced risk of stroke associated with the drug. Read more

New Insight into How Metformin Works

A new study shows that metformin, a common type 2 diabetes drug, may have a previously unknown mechanism of action, involving the release of sugars in the blood from the intestines into the stool. Better understanding of how metformin works could eventually lead to development of new and improved diabetes medications.  Read more

Consumer Advocacy Group Wants SGLT-2 Warnings for Type 1 Patients

Public Citizen, a consumer advocacy group, is urging the FDA to strengthen its warnings that SGLT-2 inhibitors are associated with increased risk of diabetic ketoacidosis, due to hundreds of cases of this potentially fatal condition in people with type 1 diabetes. SGLT-2 inhibitors are not currently approved for use in type 1 diabetes in the […]

Chrononutrition: Is Meal Timing as Important as What You Eat?

Some researchers are investigating the emerging field of chrononutrition, which is based on the timing of when a person eats. According to chrononutrition, coordinating food intake with the body’s daily rhythms will help with management of type 2 diabetes. Read more

Glycemic Control in Young Americans with Diabetes Getting Worse

Blood glucose control among youth with diabetes has not improved since 2002 levels, and has actually gotten worse in some subgroups, according to data presented at the virtual American Diabetes Association (ADA) 2020 Scientific Sessions. This is despite increased availability of diabetes technology and new therapies in recent decades, and despite more aggressive recommended blood […]

New Insights on Dual and Triple Drug Therapy for Type 2

In treating type 2 diabetes, the first-line option is typically metformin. When metformin alone isn’t achieving the patient’s goals, the second and third-line options for pharmacological treatment are complex, with multiple drug classes and multiple drugs within those classes. A new analysis looks at the pros and cons of some key combinations. Read more

People with Type 1 at Risk for COVID-19 Complications

Researchers continue examining the relationship between diabetes and coronavirus. In a new study looking specifically at type 1 diabetes, they found that about half the people in the study with type 1 and COVID-19 had abnormally high blood sugar, which demonstrates how COVID-19 can complicate blood sugar control. Read more

Teen Body Mass Index and Diabetes

A large study of Israeli teen body mass index (BMI) found body mass in adolescence affects risk of developing type 2 as an adult, with young women with obesity most at risk for the disease. Read more

Signs of Adult Diabetes Risk May be Visible in Childhood

Signs a child may grow up to be susceptible to type 2 diabetes as an adult can be seen in children as young as 8 years of age, researchers say. They looked at the effects of a genetic risk score for developing type 2 diabetes in a large study of children in the UK, and […]

A New Class of Diabetes Drug

Imeglimin is a new, first-in-class blood-glucose-lowering drug. It is currently in phase 3 trials and has so far proven to be safe and efficient whether used alone or in combination with other drugs to lower A1C in patients with type 2 diabetes.  Read more

COVID-19 May Trigger Diabetes

It’s been well documented since the coronavirus pandemic began that people who have diabetes are at greater risk of severe complications and death from COVID-19. However, some researchers now say the relationship goes both ways: people who have been infected with COVID-19 are at risk of developing stress-related diabetes. Read more

Why Do Some Patients Not Take Metformin as Prescribed?

Long term, consistent therapy is essential with metformin for it to be effective in lowering A1c and hospitalization rates. A large UK based study set out to investigate patterns that may lead some patients to discontinuation of metformin therapy.   Read more

Vitamin A Analog May Help Treat Diabetic Retinopathy

Diabetic retinopathy, a common complication of diabetes, is a major cause of blindness in adults. A new study found that visual function in diabetic mice was significantly improved after treatment with a single dose of visual chromophore 9-cis-retinal, a vitamin A analog that can form a visual pigment in the retina cells, thereby producing a […]

Other News

ACLS Class

  • Get ACLS and PALS certified online with ACLSclass.com’s fast programs.
  • Health Partner